Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Equity Ratio (2020 - 2025)

Rani Therapeutics Holdings (RANI) has 6 years of Equity Ratio data on record, last reported at 1.18 in Q3 2025.

  • For Q3 2025, Equity Ratio fell 990.32% year-over-year to 1.18; the TTM value through Sep 2025 reached 1.18, down 990.32%, while the annual FY2024 figure was 0.1, 78.3% down from the prior year.
  • Equity Ratio reached 1.18 in Q3 2025 per RANI's latest filing, down from 0.54 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.98 in Q4 2021 and bottomed at 1.6 in Q2 2021.
  • Average Equity Ratio over 5 years is 0.25, with a median of 0.47 recorded in 2023.
  • Peak YoY movement for Equity Ratio: soared 168.58% in 2021, then plummeted 990.32% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.98 in 2021, then crashed by 30.01% to 0.69 in 2022, then plummeted by 35.87% to 0.44 in 2023, then plummeted by 78.3% to 0.1 in 2024, then plummeted by 1338.49% to 1.18 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 1.18 in Q3 2025, 0.54 in Q2 2025, and 0.22 in Q1 2025.